Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTRN12617001086358Phase 4Completed
Phase 4, open-label trial of quadrivalent influenza vaccine in influenza (2 arms), sponsored by Women's and Children's Hospital. Primary endpoints: Seroprotective HIA titre proportion and Four-fold rise in HIA titres. Started Jul 2019; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ACTRN12617001086358.